Table 2.
Clinical and demographic data of children with low-grade glioma.
| Pt. no. | Age at 1st op. (yr) | M/F | Diagnosis | Tu. location | 2nd op. | MH | Chemotherapy | Radiotherapy | Death |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.9 | F | PA | OTG | n | n | y | n | n |
| 2 | 16.9 | F | PA | chia–ht | y | n | y | n | n |
| 3 | 23.4 | F | PA | OTG | n | n | y | n | n |
| 4∗ | 2 | M | PA | chia–ht | y | n | y | y | n |
| 5 | 3 | F | PA | chia–ht | y | NF-1 | y | n | y |
| 6 | 1.1 | M | PA | chia–ht | n | n | y | n | n |
| 7 | 8.4 | M | PA | chia–ht | n | n | n | n | n |
| 8 | 4.6 | F | PA | OTG | n | NF-1 | y | n | n |
| 9 | 3.8 | F | PA | chia–ht | n | n | n | n | n |
| 10 | 1.4 | F | PA | chia–ht | n | n | y | n | n |
| 11 | 2.7 | M | PA | PF | y | n | y | n | n |
| 12 | 10.11 | M | PA | Temporal | n | NF-1 | n | n | n |
| 13 | 16.6 | F | PA | PF | n | n | n | n | n |
| 14 | 16.1 | M | PA | PF | y | n | n | n | n |
| 15 | 4.1 | M | PA | PF | n | n | n | n | n |
| 16 | 12.7 | F | PA | Temporal | y | n | n | n | n |
| 17 | 14.11 | M | PA | Pineal | n | n | n | n | n |
| 18 | 5 | F | PA | PF | n | n | n | n | n |
| 19 | 8.1 | F | PA | PF | n | n | n | n | n |
| 20 | 2 | F | PA | PF | y | n | n | n | n |
| 21 | 14.1 | M | PA | PF | y | n | n | n | n |
| 22 | 6.1 | F | PA | PF | y | n | y | n | n |
| 23 | 12.4 | M | PA | PF | n | n | n | n | n |
| 24 | 1.9 | M | PA | PF | y | n | n | n | n |
| 25 | 6.8 | F | PA | Ventricle | n | n | n | n | n |
| 26 | 15 | M | PA | PF | n | n | n | n | n |
| 27 | 2.5 | M | Astroblastoma | Temporal | y | n | n | n | n |
| 28 | 14.3 | F | PA | Temporal | n | n | n | n | n |
| 29 | 22 | F | FA | Temporal | n | n | n | y | n |
| 30 | 7 | F | PA | Ventricle | y | n | n | n | n |
| 31 | 11 | F | PA | Brainstem | n | n | y | n | n |
| 32 | 2.2 | M | Gangliocytoma | PF | n | LD | n | n | n |
| 33 | 0.1 | F | FA | Temporal | n | n | n | n | n |
| 34 | 4.2 | M | PA | Thalamus | n | n | n | n | n |
| 35 | 10.1 | F | PA | PF | n | NF-1 | y | n | n |
| 36 | 3.5 | M | Pilomyxoid ast. | PF | n | n | n | n | n |
| 37 | 17 | F | Ganglioglioma | Brainstem | y | n | n | n | n |
| 38 | 3.1 | M | Ganglioglioma | Temporal | n | n | n | n | n |
| 39 | 12.8 | M | Ganglioglioma | Temporal | n | n | n | n | n |
| 40 | 14.4 | M | Ganglioglioma | Occipital | y | n | n | n | n |
| 41 | 14 | F | Ganglioglioma | Temporal | y | n | n | n | n |
| 42 | 14.2 | F | Ganglioglioma | Temporal | n | n | n | n | n |
| 43 | 9.11 | M | Ganglioglioma | Temporal | n | n | n | n | n |
| 44∗ | 12.11 | F | PXA | Temporal | y | n | y | y | y |
| 45 | 11 | F | PXA | Temporal | y | n | n | n | n |
| 46 | 14.9 | F | PXA | Temporal | y | n | n | n | n |
| 47 | 5.8 | M | SEGA | Ventricle | n | TS | n | n | n |
| 48 | 3.4 | M | SEGA | Ventricle | y | TS | n | n | n |
MH = medical history; PA = pilocytic astrocytoma; FA = fibrillary astrocytoma; PXA = pleomorphic xanthoastrocytoma; SEGA = subependymal giant cell astrocytoma; OTG = optic tract glioma; chia-ht = chiasmatic–hypothalamic; PF = posterior fossa; NF-1 = neurofibromatosis type 1; TS = tuberosclerosis; LD = Lhermitte–Duclos. ∗Patients 4 and 44 multiple surgeries due to progression (4) and recurrence (44) (indicated by asterisk).